Lopid Patent Term Restoration and Fairness Act of 1987: Hearing Before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, First Session, October 8, 1987, Volume 4U.S. Government Printing Office, 1988 - 350 pages |
Other editions - View all
Common terms and phrases
apolipoprotein atherosclerosis bill blood Capsules cardiovascular cent Chairman changes cholesterol cholesterol levels cholestyramine clofibrate Committee concentrations CONGRESS THE LIBRARY coronary heart disease decrease diabetic diet dose dyslipidaemic effect of gemfibrozil fatty acid composition FDA approval fibre Finland Food and Drug gemfibrozil treatment HDL-cholesterol Health heart attacks Helsinki Heart Study high density lipoprotein hypercholesterolaemia hypertension incidence increase ischaemic heart disease Journal KASTENMEIER Kaukola laboratory legislation LIBRARY OF CONGRESS lipid lowering Lipid Research Clinics lipid-lowering lipoprotein lipase lipoprotein lipase activity Lithell long-term Lopid Lopid patent low density lipoprotein LRC-CPPT Manninen market exclusivity Medical metabolism mmol/l MORRISON mortality myocardial infarction Parke-Davis patent extension patent term extension patients pharmaceutical Phase IV study placebo Primary Prevention Trial reduction regulatory Royal Society serum cholesterol serum lipid serum triglyceride significant Society of Medicine Subcommittee Table Term Restoration Act therapy triglyceride levels triglycerides Vessby VLDL Warner-Lambert Waxman-Hatch WILLIAMS
Popular passages
Page 113 - Abell, LL, Levy, BB, Brodie, BB, and Kendall, FE, A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity, J.
Page 113 - Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
Page 124 - Levy RI, Brensike JF, Epstein SE, et al: The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention Study.
Page 73 - I am a partner in the Washington, DC law firm of Covington & Burling. I have been asked to present testimony on patent term restoration.
Page 242 - For the purposes of paragraph (2)(B), the term "due diligence" means that degree of attention, continuous directed effort, and timeliness as may reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period.
Page 289 - Kagan A.: Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.
Page 8 - Mr. BOUCHER. Thank you very much, Mr. Chairman. I want to commend you...
Page 67 - HL-07182 from the National Heart, Lung and Blood Institute of the National Institutes of Health, and by the American Heart Association, Indiana Affiliate, Inc.
Page 154 - ... morphology have been observed. Peroxisome proliferation has been shown to occur in humans with either of two other drugs of the fibrate class when liver biopsies were compared before and after treatment in the same individual. Administration of approximately three or ten times the human dose to male rats for 10 weeks resulted in a dose-related decrease of fertility. Subsequent studies demonstrated that this effect was reversed after a drug-free period of about eight weeks, and it was not transmitted...
Page 9 - I want to commend you for scheduling this hearing, and I look forward to the testimony of our witnesses this morning, and in particular to the responses to the questions that I just asked.